FdaApplication
NDA 020733
Identifiers
- fda_app_no: NDA020733
Properties
| Property | Value |
|---|---|
| applicant_name | INDIVIOR INC |
| application_type | NDA |
| approval_date | 2002-10-08 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUBOXONE | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;SUBLINGUAL |
| SUBOXONE | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;SUBLINGUAL |
2 products